Assura

KKR Enters UK Healthcare Market with $1.6 Billion Acquisition of Assura

10 days ago

In a significant move within the healthcare sector, KKR, a leading global investment firm, has reached an agreement to acquire Assura, a prominent UK-based medical landlord, for an impressive $1.6 billion. This acquisition marks a strategic entry for KKR into the burgeoning healthcare real estate market in the United Kingdom, showcasing the growing demand for healthcare facilities driven by an aging population and increased healthcare needs.

KKR-Led Coalition Increases Bid to Acquire Assura with $1.6 Billion Offer

1 month ago

In a bid to acquire the UK-based healthcare property firm Assura, a consortium led by KKR has sweetened its offer, now amounting to $1.6 billion. This latest proposal marks a significant increase from prior offers and is indicative of the growing appetite for healthcare investments within the real estate sector. The revised bid highlights the strategic importance of owning and managing healthcare properties, especially in the current market environment.

Assura Declines KKR's $1.6 Billion Takeover Offer: A Closer Look

2 months ago

In a significant development within the real estate investment sector, UK landlord Assura has officially turned down a takeover bid from the private equity firm KKR, valued at approximately $1.6 billion. This decision has left analysts and stakeholders pondering the implications for both Assura and the broader market.

Chinese Health Watchdog Stands Firm on Quality of Domestic Generic Drugs Amid Rising Concerns

2 months ago

The Chinese National Medical Products Administration (NMPA) has recently issued a strong defense regarding the quality standards of local generic medications. This statement comes in light of growing scrutiny and skepticism towards the efficacy and safety of domestically produced pharmaceuticals. The regulatory body emphasized that ongoing rigorous quality control measures are in place to ensure that generic drugs meet international standards.